Total medical devices industry cross border deals worth $3.5bn were announced globally for May 2021, with the $830m private equity deal with Caris Life Sciences being the sector’s biggest investment, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 11.1% over the previous month of $3.97bn and a rise of 17.3% when compared with the last 12-month average of $3.01bn.

In terms of number of cross border deals, the sector saw a rise of 25.00% with 50 deals in May 2021 when compared to the last 12-month average of 40 deals.

In value terms, North America led the activity with cross border deals worth $2.22bn in May 2021.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Medical Devices industry cross border deals in May 2021: Top deals

The top five cross border deals accounted for 62.1% of the overall value during May 2021.

The combined value of the top five cross border deals stood at $2.2bn, against the overall value of $3.5bn recorded for the month.

The top five medical devices industry cross border deals of May 2021 tracked by GlobalData were:

1) L.P, Canada Pension Plan Investment Board, ClearBridge Investments, Coatue Management, Columbia Threadneedle Investments, Eaton Vance, Fidelity Management & Research, First Light Asset Management, Highland Capital Management, Millennium Management, Orbimed Advisors, Pura Vida Investments, Rock Springs Capital Management, Silver Lake Management, T Rowe Price Associates, TPG Sixth Street Partners and Tudor Investment’s $830m private equity deal with Caris Life Sciences

2) The $540m venture financing of Noom by Novo Holdings, Oak HC/FT Partners, RRE Ventures, Samsung Ventures Investment, Sequoia Capital Operations, Silver Lake Management and Temasek Holdings (Private)

3) NeoGenomics’ $390m acquisition of Inivata

4) The $235m private equity deal of Cue Health by ACME Capital, CAVU Venture Partners, Decheng Capital, Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms, MSD Capital and Perceptive Advisors

5) China Investment, EDBI, Novo Holdings and Vivo Capital’s venture financing deal with Esco Micro for $200m.